EP1430303A1 - Systeme de bande d'essai a relief - Google Patents

Systeme de bande d'essai a relief

Info

Publication number
EP1430303A1
EP1430303A1 EP02770522A EP02770522A EP1430303A1 EP 1430303 A1 EP1430303 A1 EP 1430303A1 EP 02770522 A EP02770522 A EP 02770522A EP 02770522 A EP02770522 A EP 02770522A EP 1430303 A1 EP1430303 A1 EP 1430303A1
Authority
EP
European Patent Office
Prior art keywords
test strip
test
wicking layer
sample
fluid sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02770522A
Other languages
German (de)
English (en)
Inventor
Joel S. Douglas
Edward P. Perez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Publication of EP1430303A1 publication Critical patent/EP1430303A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte

Definitions

  • the present invention relates to a system and method for determining the presence or concentration of analytes or biological agents in a sample of bodily fluid using a specific amount of membrane imbibed with dry reagent.
  • the meter and a single use, reagent bearing test strip is used to measure the concentration of glucose in a bodily fluid such as whole blood or interstitial fluid (ISF).
  • ISF interstitial fluid
  • the study, known as the DCCT proved that long term tight control of the blood glucose levels in patients had a direct relationship to the health of the patient.
  • One way for the medical profession to monitor the control of a patient is for the patient to use a blood glucose monitoring system.
  • One of the main obstacles to testing is the sample size needed to perform the test. As patients age and their circulation decreases, the ability to extract an adequate sample of body fluid is affected. A test which more efficiently utilizes the bodily fluid would aid in reducing the problems associated with larger sample size tests.
  • Current blood glucose monitoring devices such as the One Touch systems manufactured by LifeScan, Inc. of Milpitas, Calif.
  • U.S. Pat. No. 4,637,403 to Garcia et al., describes an integrated system which provides a method by which the patient lances the finger to get a sample of blood which is then used by the device to read the quantity of analyte in the sample.
  • This system uses a complex reflectance system to read the analyte level in the sample.
  • U.S. Pat. No. 5,279,294, to Anderson et al. describes a hand held, shirt pocket device for quantitative measurement of glucose or analytes in biological fluids.
  • the device has a sophisticated electronics system and a sampling system integrated into one device to determine the quantity of analyte in a bodily fluid sample
  • U.S. Pat. No. 5,515,170, to Matzinger et al. describes the difficulties of keeping a strip holder and optics system clean and the need to present the test strip in the proper perspective to the optics.
  • European Patent Specification 0 351 891 Bl, to Hill et al. describes an electrochemical system and electrodes which are suitable for the in vitro determination of blood glucose levels.
  • the system requires the use of expensive electrodes and a sophisticated reader to determine blood glucose levels.
  • U.S. Pat. No. 5,580,794, to Allen et al. describes a single use disposable measuring device for determining the presence and amount of a substance in a biological fluid using reflectance methods. This system utilizes optics and electronics packages which are mated in a single plane.
  • U.S. Pat. No. 5,962,215 to Douglas et al., describes a series of semiquantitative, single use devices which are used to determine the level of an analyte in a biological sample. These devices do not require blood removal or color matching.
  • EP 0759 555 A2 to Douglas et al., describes a multilayer reagent test strip which measures the concentration of analyte in a liquid sample that is applied to it.
  • An object of the present invention is to provide a method for measuring the amount of analyte in a sample of biological fluid using a simple, low sample volume, reagent test strip with a built in metering system.
  • Another object of this invention is to provide reagent test strips that can meter the sample into the reaction matrix.
  • the method of this invention involves the use of single use test strips capable of reading small sample sizes and determining the amount of an analyte in the small sample.
  • the low sample size feature of the strip permits the patient to use less invasive systems to acquire a sample than the 21 gauge lancing devices in current use.
  • the device is structured with a capillary to meter a specific quantity of sample to the test matrix, thereby eliminating a significant source of error associated with short sampling.
  • the capillary is designed so that, when placed in contact with a sample of bodily fluid, it transfers the sample to the test matrix. If the sample is insufficient to travel the full length of the capillary, then the sample does not reach the test matrix and will not wick into the test matrix, which prevents the patient from short sampling the test strip.
  • the user can add additional sample to the capillary to complete the test. Once the sample contacts the test matrix, the sample will wick into the test matrix until the test matrix is filled, then stop. Excess sample remains in the capillary and serves as a signal to the patient that the test matrix has the correct amount of sample for the test. This provides many advantages to the patient including the elimination of wasted strips due to short sampling which results in a substantial cost savings for the patient and reduces the number of inaccurate tests from marginal samples.
  • the capillary design also provides another interesting benefit. As blood travels down through the capillary to the test area, the blood warms the peg, thus regulating the temperature of the strip and the test. This is beneficial in two ways; the first is that each test is performed under somewhat controlled conditions, regardless of whether or not the surrounding temperature is warm or cold. Second, this effect alleviates the problem of fogging over the test area. This is a problem with many blood glucose monitors when testing in cooler ambient conditions. The formation of a captivated microtitration zone is described in U.S. Pat. No. 5,872,713 Douglas et al.
  • the microtitration zone can be achieved with a specific volume by following a simple series of steps: (a) applying a specific amount of reagent such that it does not saturate the matrix and is developed to indicate a specific analyte, (b) drying the reagent so that the active ingredients adhere to the substrate of the matrix, (c) embossing or compressing the matrix to collapse the matrix surrounding the reaction zone so that the void volume of the resulting test matrix microtitration volume is approximately equal to the sample size desired, (d) installing it into a performed pocket which completely surrounds all the circumference of the pillow where the capillary is in communication with the top side/sample side of the pillow, and (e) sealing the system together.
  • the embossed/collapsed areas have had their void volume reduced to approximately zero and the test matrix reaction zone forms a small bibulous pillow which retains its void volume and has the desired total volume. This limits the ability of the reagents imbibed into the embossed matrix to participate in the reaction of the result zone.
  • the test pad can be made from various matrix materials which will hold the test reagent in a dried form including polyethersulphone (German sciences Supor 200D), polysulphone (Memtec filtration asymmetric membrane) and nylon (Pall biodyne).
  • the wicking material which can be selected from various materials, including Pall Accuwick and Whatman 41, which provide a high enough capillary action to wick and absorb the sample from the capillary peg and spread it into and fill the reaction matrix microtitration volume.
  • the applied bodily fluid reacts with the reagents impregnated in the test pad within the test strip and the resulting color change is read by the optics system of the meter adapted to read the strip.
  • the patient uses the test strip by removing it from the packaging and placing it into a meter designed to utilize the test strip.
  • the patient turns the meter on or it can be automatically started from the test strip insertion.
  • the patient uses either a sampler from the kit or one procured separately to draw a sample of capillary blood. This sample is applied to the test strip, the meter reads the sample, and the meter displays the result after an appropriate time.
  • the assembly includes a support member that defines an aperture adapted to receive a bodily fluid sample and a cover member.
  • a test strip is compressed between the support member and the cover member to form an embossed pillow within the aperture.
  • the embossed pillow is adapted to absorb the bodily fluid sample.
  • the test strip has an incision surrounding the embossed pillow to minimize leakage of the bodily fluid sample from the embossed pillow.
  • test strip assembly that includes a wicking layer for collecting a bodily fluid sample and a support member.
  • the support member defines an opening and has a blade extending around the opening. The blade contacts the wicking layer to minimize flow of the fluid sample in the wicking layer from the opening.
  • a further aspect of the present invention concerns a test strip.
  • the test strip includes a test matrix to test a bodily fluid sample.
  • a wicking layer is provided over the test matrix.
  • the wicking layer has an embossed pillow for absorbing the bodily fluid sample.
  • the wicking layer has an incision surrounding the embossed pillow to minimize leakage of the bodily fluid sample from the embossed pillow.
  • FIG. 1 is an exploded, side elevation view of one embodiment of a test pad matrix and wicking layer prior to being embossed in a die formed by plates.
  • FIG. 2 is a cross-sectional view of one embodiment of a test pad matrix and wicking layer during embossing in a die formed by plates.
  • FIG. 3 is an exploded perspective, cut away view of the test pad matrix, wicking layer and upper and lower plates of the embossing die.
  • FIG. 4A is an assembled view and 4B is an exploded perspective view of one embodiment of the strip showing assembly of the handle, test pad, wicking layer, and capillary.
  • FIG. 5 is an enlarged, cross-sectional view of a test strip constructed according to the present invention.
  • FIG. 6 is an exploded, cross-sectional view of an alternative embodiment of the test strip in accordance with the present invention.
  • FIG. 7 is a cross-sectional side view of the alternative embodiment of the test strip as assembled.
  • FIG. 8 is an exploded, cross-sectional side view of another alternative embodiment of a test strip in accordance with the present invention.
  • FIG. 9 is a cross-sectional side view of the test strip of Figure 8 as assembled for use.
  • FIG. 10 is an enlarged, cross-sectional view of a test strip constructed according to another embodiment of the present invention. DESCRIPTION OF SELECTED EMBODIMENTS
  • a preferred embodiment of the invention creates a microtitration zone which permits the accurate testing of a small fluid sample and prevents oversampling, while the integrated capillary provides a means to eliminate the problems associated with short sampling which frequently occurs in the current commercial products.
  • the capillary also provides a means of absorbing the fluid sample from a non-fingerstick location. This permits the use of non-traditional lancing systems.
  • the small test pad used in this invention reduces the cost of the matrix employed and the quantity of expensive reagents needed to conduct an accurate assay using an oxidase and peroxidase chemistry. With a smaller test pad, a smaller sample volume is adequate.
  • the capillary acts as a retaining chamber where a sample of appropriate volume is initially collected and then delivered to the test pad. The sample is only delivered to the test pad when a sufficient amount of sample has been collected within the capillary.
  • the capillary may be constructed to further include a fluid chamber. The fluid chamber may be disposed adjacent the test media, such that in use, the distal end of the capillary is placed in contact with a bodily fluid to be sampled. The bodily fluid is received within the capillary through capillary action or other means such as a wicking material.
  • the bodily fluid fills the fluid chamber.
  • the sample of bodily fluid collected in the fluid chamber may then be deposited upon the test media.
  • a benefit of using a fluid chamber is that a smaller sized sample may be utilized to perform a desired test because the entire amount of bodily fluid needed for the test can be accurately delivered to a test site, thereby reducing the overall amount of sample needed to perform the test.
  • the use of a fluid chamber to collect the sample may also lead to fewer failed tests due to inadequate sample volume, because the sample will not be delivered to the test media until a sufficiently sized sample is collected.
  • the fluid chamber has been described in use with a capillary, it is contemplated that other collection devices may be utilized with the fluid chamber of the present invention.
  • the fluid chamber may be included within a test strip wherein the sample is placed on a portion of the test strip and transported to the fluid chamber.
  • the descriptions above should not be considered limiting and are intended to be exemplary.
  • the test strip is comprised of a test pad situated in a test pad holder.
  • This holder provides a means for accurately positioning the test pad with respect to the optics system in the meter and for providing a means for blocking ambient light from affecting the analysis.
  • the test pad is impregnated with the appropriate chemistry to permit a colorimetric analysis of the analyte being tested, and must therefore provide a stable absorbent substrate. If the system is developed with an electrode based system, the function of the test pad holder is to position the electrode contacts on the strip with those corresponding to the meter.
  • the test pad can be made from various materials which will hold the test reagent in a dried form, including polyethersulphone (Gelman Sciences Supor 200D), polysulphone (Memtec filtration asymmetric membrane) and nylon (Pall Biodyne).
  • the wicking layer can likewise be selected from various materials, including Pall Accuwick and Whatman 41, which provide a high enough capillary action to absorb the sample and spread it to the reaction matrix.
  • the test strip of this invention provides a support for the test pad and the capillary peg contacting the test pad.
  • the peg positively seats in the meter in a detent and is locked from rotation by a corresponding key in the test strip which fits into a slot in the meter test strip holder.
  • the test strip holder is positioned to the optics block using pins on the optics block assuring proper alignment of the test strip. It also seals the optics area from ambient light and any excess blood contamination.
  • the signal producing system impregnated in the test pad matrix can be formed from different indicator systems, such as 3-methyl-2-benzothiazolinone hydrazone (MBTH) and 8-anilino-l-naphthalenessulfonate(ANS) [U.S. Pat. No. 5,453,360 to Yu], MBTH and 3-dimethylaminobenzoic acid (DMAB) [U.S. Pat. No. 5,049,487 to Phillips et al.],
  • MBTH 3-methyl-2-benzothiazolinone hydrazone
  • ANS 8-anilino-l-naphthalenessulfonate
  • DMAB 3-dimethylaminobenzoic acid
  • reagent pad 3-methyl-2-benzothiazolinone-hydrazone-sulfonate sodium salt (MBTHS) and -Ethyl-N-(3-sulfopropyl)aniline (ALPS) [U.S. Pat. No. 4,396,714 to Maeda et al.].
  • MTHS 2-benzothiazolinone-hydrazone-sulfonate sodium salt
  • APS -Ethyl-N-(3-sulfopropyl)aniline
  • reagents are impregnated into a porous membrane by submerging the dry membrane into a reagent dip. Excess fluid is wiped from the membrane surface and the membrane is gently dried in an oven. At this point, subsequent dipping and drying can be conducted.
  • a preferred embodiment for a two dip process is:
  • the color formed after applying the bodily fluid to the reagent test pad is proportional to the amount of analyte in the applied sample.
  • the meter measures the change in reflectance due to the development of the specific color generated by the indicator. This is either used as the input to a function which relates reflectance to analyte level or to a table which correlates reflectance value to analyte level.
  • the function or the table is stored within the meter system for it to produce and display a reading of the analyte level. While most meters in use today employ functions to convert reflectance readings to analyte concentration, this approach requires that the function be stable and well understood.
  • the use of a look up table permits the storage of specific values for reflectance and their corresponding analyte levels.
  • the meter uses this table and interpolates between the table values to give relatively accurate readings. This is achievable in a system such as that described by this invention as the table can quickly be generated for each reagent lot produced.
  • the devices of this invention using a read-once calibration chip, or being fully disposable, can use a lot- specific look up table to convert reflectance reading to analyte levels.
  • FIG. 1 shows an elevation view of the un-embossed layers, wicking layer 5, test matrix layer 4, and top layer 1 between the die 17 formed from top plate 16 containing hole 18 and bottom plate 15 containing hole 18 A.
  • FIG. 2 shows an elevation view of the embossed or compressed layers, wicking layer 5, test matrix layer 4, and top layer 1 between the die 17 formed from top plate 16 containing hole 18 and bottom plate 15 containing hole 18 A.
  • Hole 18 in die plate 16 forms the microtitration pillow 21 in the wicking layer 5 and in test matrix layer 4.
  • the areas of the layers surrounding pillow 21 are compressed to make them essentially impervious to sample liquid flow, thus forming the microtitration volumetric area around pillow 21.
  • Hole 18A allows for the test strip to be placed in an optical meter whereby a color change of the top layer and/or matrix layer can be measured.
  • FIG. 3 shows an exploded perspective view of the embossed or compressed layers, wicking 5, test matrix 4, and top layer 1 as formed between the die 17 formed from top plate 16 and bottom plate 15 containing hole 18A.
  • FIG. 4A The assembly of a test strip 20 shown in FIG. 4A is accomplished as shown in FIG. 4B.
  • bottom or support member 6 which has the capillary peg 7 and capillary 10 integrally molded therein (e.g., by injection molding) and constructed so that microtitration pocket 8 has breather holes 9 located within the microtitration pocket 8.
  • capillary peg 7 can be formed as a separate element and assembled into support member 6 if desired.
  • FIG. 2 shows the formation of the microtitration pillow 21 in matrix 4 and wicking layer 5.
  • the microtitration pillow 21 is formed using die 17 formed from top plate 16 and bottom plate 15.
  • Test matrix pad 4 is formed from a bibulous matrix which has been impregnated with a reagent system comprised of enzymes, indicators and blood separation agents and the wicking matrix pad 5 provides a means of spreading the sample over the test pad 4.
  • Layers or pads 4 and 5 are preferably embossed or compressed prior to assembly with layers 1 and 6.
  • the holes 22 and 23 formed in the top layer 1 and alignment keys 11 and 12 formed in holder 6 provide a means of aligning the test strip assembly including pillow 21 and hole 18A to the microtitration pocket 8.
  • the breather holes 9 provide an escape path for trapped air in the assembly pillow 21 when wicking the sample up the capillary 10 and into pillow 21.
  • Figure 5 shows an additional preferred feature of the present invention where capillary peg 7 and capillary tube 10 are formed with a protruding collar 25 extending from capillary tube 10 to engage and further compress pillow 21.
  • This feature provides a seal between capillary tube 10 and the surface of wicking layer 5, which better forces the sample flow from capillary tube 10 into the interior of wicking layer 5 to better distribute the sample throughout test matrix layer 4 and completely fill microtitration volume 8 and to better prevent sample from flowing between the surface of wicking layer 5 and the surface of the end of capillary peg 7.
  • FIGS 6 and 7 illustrate a test strip 200 according to another embodiment of the present invention.
  • the test strip 200 includes a top layer 1, a test matrix 204 and a wicking layer 205 of the type as described above. As shown, the test matrix 204 is sandwiched between the top layer 201 and the wicking layer 205. Layers 204 and 205 as well as the test matrix 204 are pressed between a bottom plate
  • openings 18A and 218 have a generally cylindrical shape. However, as should be appreciated, openings 18A and 218 can be shaped differently. Bodily fluid samples are collected through the opening 218 in the top plate 216, and the opening 18A in the bottom plate 15 allows the sample collected on the test matrix 204 to be analyzed.
  • plate 216 has an interior surface 219 with a blade member 220 projecting therefrom towards plate 15.
  • the blade 220 is integrally formed with the top plate 216, and in another embodiment, the blade 220 is a separate component attached to plate 216.
  • the top plate 216 and the bottom plate 115 are compressed to make the portion of the wicking layer 205 and the test matrix 204 adjacent the aperture 218 virtually impervious to a bodily fluid sample.
  • the wicking layer 205 and the test matrix 204 are embossed to form a microtitration area or pillow 221, which is able to absorb the fluid sample.
  • the blade 220 in one embodiment presses into the wicking material 205 and is sufficiently sharp to form an incision or cut 222 at least through part of the wicking layer 205 in order to minimize the amount of fluid leakage from the microtitration pillow 221.
  • the blade 220 only compresses the test strip 200 around the microtitration pillow 221 making the periphery of the micortitration pillow 221 impervious to fluid so as to minimize fluid leakage from the microtitration pillow 221.
  • the blade 220 in the illustrated embodiment has a generally cylindrical shape. However, it should be appreciated that the blade 220 can be shaped differently.
  • the blade 220 has a length L that is sized to only cut the incision 222 through part of the wicking layer 205 so that the microtitration pillow 221 of the wicking layer 205 remains attached to the remainder of the test strip 200. In another embodiment, the blade 220 is sized to cut the incision 222 completely through the wicking layer 205.
  • the microtitration pillow 221 of the wicking layer 205 in one form of this embodiment bonded to the test matrix 204, and in another form, the microtitration pillow 221 of the wicking layer 205 is retained in opening 18 through frictional engagement.
  • the blade 220 has a closed, continuous shape so that the incision 222 encircles the microtitration pillow 221.
  • the incision 222 in the illustrated embodiment is continuous to minimize fluid leakage from the microtitration pillow 221, it should be understood that the incision 222 can be formed in a discontinuous manner such that fluid leakage prevention is not severely compromised.
  • the blade 220 in another embodiment can include cut out sections that form retaining webs in the wicking layer 205 such that the formed incision 222 is discontinuous.
  • the blade 220 has a generally cylindrical shape to coincide with the shape of opening 218.
  • inner surface 224 of opening 218 is flush with inner surface 226 of the blade.
  • the incision 222 is formed at the periphery of the microtitration pillow 221 in order to effectively destroy the wicking function of the material adjacent the incision 222. This in turn minimizes leakage of the fluid sample from the microtitration pillow 221. Minimizing leakage from the microtitration pillow 221 reduces the amount of fluid required for the fluid sample.
  • the wicking layer 205 distributes the sample across the area of the opening 218, and the blade 220 acts to prevent any sample from flowing beyond it. Since the blade 220 prevents fluid from passing outside the area of the aperture 218, less fluid needs to be collected.
  • a test strip 300 includes top layer 1, test matrix layer 4 and a wicking layer 305, which is sandwiched between bottom plate 15 and top plate 16.
  • a fluid sample is collected on the test strip 300 through opening 18.
  • Opening 18A enables a test device to perform a measurement upon the sample collected the test strip 300, such as a colormetric measurement in which the reflectance of the collected sample is measured in order to determine the amount of glucose in the sample.
  • the wicking layer 305 and test matrix layer 4 are pre- embossed so as to form a microtitration pillow 321.
  • the microtitration pillow 321 is formed in the test strip 300 in opening 18 when the test strip 300 is pressed between the top plate 16 and the bottom plate 15 ( Figure 9).
  • the wicking layer 305 has an incision 322 formed therein before assembly with the other layers of the test strip 300. As shown, the incision 322 only partially cuts through the wicking layer 305. It should be appreciated that in other embodiments the incision 322 can be formed completely through the wicking layer 305 and/or the test matrix 4. In one form, the incision 322 is pre-cut with a blade before assembly.
  • the incision 322 can be fabricated in other manners. As depicted in Figure 9, the incision 322 is formed to align with and generally correspond with the shape of the opening 18 in the top plate 16 so that the incision 322 surrounds the microtitration pillow 321 formed in the test strip 300.
  • the incision 322 formed in the wicking layer 305 interrupts fluid flow in the wicking layer 305 to the area surrounding the microtitration pillow 321.
  • a sample of bodily fluid is placed upon the wicking layer 305 whereby the sample spreads across the microtitration pillow 321.
  • the incision 322 prevents the bodily fluid from flowing past the microtitration pillow 321 defined by the aperture 18. By not allowing the fluid sample to flow beyond the aperture 18, less fluid is wasted so that a smaller fluid sample is needed.
  • FIG 10 illustrates an enlarged view of a bodily fluid sampling assembly 400 incorporating test strip 200, according to another embodiment of the present invention.
  • assembly 400 includes a support member 406 that has capillary peg 7, cover member 15, and test strip 200 sandwiched between the support member 406 and the cover member 15.
  • the support member 406 defines a microtitration pocket 8 that fluidly communicates with a capillary tube 10 integrally formed within the capillary peg 7.
  • the capillary tube 10 is used to draw a bodily fluid sample into the microtitration pocket 8.
  • the capillary peg 7 is integrally formed with the support member 406. Nonetheless, it should be understood that the capillary peg 7 can be formed as a separate component and attached to the support member 406.
  • the support member 406 has a protruding collar 25 that extends from the capillary tube 10 in the microtitration pocket 8 in order to compress the test strip 200.
  • the support member 406 further includes a blade member 220 that surrounds and is aligned with the periphery of the microtitration pocket 8.
  • the cover member 15 defines a sensor aperture 18A that is aligned with the microtitration pocket 8.
  • the test strip 200 includes top layer 1, test matrix 204 and wicking layer 205.
  • a microtitration pillow 221 in the test strip 200 is formed within the microtitration pocket 8.
  • the protruding collar 25 engages and compresses the microtitration pillow 221 to improve the seal between the capillary tube 10 and the wicking layer 205.
  • This configuration improves distribution of the bodily fluid sample within the test matrix 204.
  • the blade 220 forms an incision 222 in the test strip 200 around the microtitration pillow 221.
  • this incision 222 reduces the amount of bodily fluid required for a sample because less of the fluid is wasted by leaking from the microtitration pillow 221.
  • the blade 220 does not form the incision 222 in the test strip 200. Instead, the blade 220 compresses the periphery of the microtitration pillow 221 in order to make the periphery of the pillow 221 substantially impervious to fluid so as to minimize the amount of fluid required for a sample.

Abstract

L'invention concerne un dispositif d'échantillonnage de liquides organiques qui comprend un support (216) pourvu d'une ouverture (218) prévu pour recevoir l'échantillon de liquide organique, et d'un couvercle (15). Une bande d'essai (200) est comprimée entre le support (216) et le couvercle (15) pour former un coussin en relief (221) avec l'ouverture (218). Le coussin en relief (221) est conçu pour absorber l'échantillon de liquides organiques. La bande d'essai (200) est pourvue d'une entaille qui entoure le coussin en relief (221) et qui permet de réduire les fuites d'échantillons de liquides organiques du coussin en relief (221). Le support (216) peut également comprendre une lame (220) qui entoure l'ouverture (218) et qui sert à former l'entaille autour du coussin en relief (221).
EP02770522A 2001-09-17 2002-09-17 Systeme de bande d'essai a relief Withdrawn EP1430303A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US217337 1988-07-11
US32342601P 2001-09-17 2001-09-17
US323426P 2001-09-17
US21733702A 2002-08-12 2002-08-12
PCT/US2002/029327 WO2003025574A1 (fr) 2001-09-17 2002-09-17 Systeme de bande d'essai a relief

Publications (1)

Publication Number Publication Date
EP1430303A1 true EP1430303A1 (fr) 2004-06-23

Family

ID=26911848

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02770522A Withdrawn EP1430303A1 (fr) 2001-09-17 2002-09-17 Systeme de bande d'essai a relief

Country Status (4)

Country Link
EP (1) EP1430303A1 (fr)
JP (1) JP2005526953A (fr)
CA (1) CA2460073A1 (fr)
WO (1) WO2003025574A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576416B2 (en) * 2001-06-19 2003-06-10 Lifescan, Inc. Analyte measurement device and method of use
US7625721B2 (en) 2004-02-03 2009-12-01 Polymer Technology Systems, Inc. Non-precipitating bodily fluid analysis system
US7435577B2 (en) 2004-02-03 2008-10-14 Polymer Technology Systems, Inc. Direct measurement of chlolesterol from low density lipoprotein with test strip
EP1779119B1 (fr) * 2004-08-17 2012-08-01 Polymer Technology Systems, Inc. Procede d'analyse d'un fluide corporel ne precipitant pas
US20060062690A1 (en) 2004-08-17 2006-03-23 Polymer Technology Systems, Inc. Apparatus and method of manufacturing bodily fluid test strip
US7803319B2 (en) 2005-04-29 2010-09-28 Kimberly-Clark Worldwide, Inc. Metering technique for lateral flow assay devices
US7858384B2 (en) 2005-04-29 2010-12-28 Kimberly-Clark Worldwide, Inc. Flow control technique for assay devices
JP2009501928A (ja) * 2005-07-21 2009-01-22 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 流体を解析する基板物質
US7279136B2 (en) 2005-12-13 2007-10-09 Takeuchi James M Metering technique for lateral flow assay devices
US7618810B2 (en) 2005-12-14 2009-11-17 Kimberly-Clark Worldwide, Inc. Metering strip and method for lateral flow assay devices
JP5659960B2 (ja) * 2011-06-09 2015-01-28 コニカミノルタ株式会社 細胞平面展開方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916056A (en) * 1986-02-18 1990-04-10 Abbott Laboratories Solid-phase analytical device and method for using same
US4994238A (en) * 1988-06-09 1991-02-19 Daffern George M Constant volume chemical analysis test device
DE4217733A1 (de) * 1992-05-29 1993-12-02 Boehringer Mannheim Gmbh Testträger zur Analytbestimmung sowie Verfahren zu dessen Herstellung
NO963207L (no) * 1995-08-03 1997-02-04 Lifescan Inc Reagenstestbånd med direkte avlesning
JP2001527216A (ja) * 1997-12-19 2001-12-25 アミラ メディカル エンボス加工されたテストストリップシステム

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03025574A1 *

Also Published As

Publication number Publication date
CA2460073A1 (fr) 2003-03-27
WO2003025574A1 (fr) 2003-03-27
JP2005526953A (ja) 2005-09-08

Similar Documents

Publication Publication Date Title
US6455324B1 (en) Embossed test strip system
DE19781162C2 (de) Teststreifen zur Analyse einer Körperflüssigkeitsprobe und zum Auswerten in einem Testinstrument
AU2005220022B2 (en) Body fluid sampling device
US4397956A (en) Means for monitoring the status of control of ketoacidosis-prone diabetics
US20120165626A1 (en) Devices, methods, and kits for determining analyte concentrations
EP0451981A2 (fr) Unité réactive à jeter après usage
WO2000013580A9 (fr) Dispositif d'evaluation d'un analysat dans un fluide anatomique, integre a une pompe a insuline
WO2003025574A1 (fr) Systeme de bande d'essai a relief
NO331851B1 (no) Innretning for provetaking av flytende medier
US7776608B2 (en) Volume meter testing device and method of use
US20080044842A1 (en) Biological Test Strip
US20040229347A1 (en) Embossed test strip system
US20030077205A1 (en) Diagnostic test optical fiber tips
US20100297601A1 (en) Small volume and ultra speed colorimetric sensor
Hook et al. Blood glucose monitors: technology for home healthcare
US8501111B2 (en) Small volume and fast acting optical analyte sensor
Cherian et al. Use of cresolphthalein complexone to measure calcium with the greiner selective analyzer, GSA IID
Wearne et al. The greiner G-300 selective analyzer—an evaluation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040419

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PEREZ, EDWARD P.

Inventor name: DOUGLAS, JOEL, S.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ROCHE DIAGNOSTICS GMBH

Owner name: F. HOFFMANN-LA ROCHE AG

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070206